Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
Optomed Plc Stock Exchange Release 25 March 2021 at 14.00, Helsinki
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
The total holdings in Optomed shares and votes held by Optomed Plc has decreased to 4.61 per cent of all of the registered shares in Optomed on 17 February 2021. Optomed has disclosed this decrease of treasury shares separately on 19 February 2021.
The total number of the Company’s registered shares amounts to 14,003,144 shares. Each share entitles to one vote.
The total position of Optomed Plc:
| % of shares and voting rights (total of A) | % of shares and voting rights through financial instruments (total of B) | Total of both in % (A+B) | |
| Resulting situation on the date on which threshold was crossed or reached | 4.61 % | - | 4.61 % |
| Position of previous notification (if applicable) | - | - | - |
Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: Shares and voting rights
| Class/type of sharesISIN code | Number of shares and voting rights | % of shares and voting rights | ||
| Direct (SMA 9:5) |
Indirect (SMA 9:6 ja 9:7) |
Direct (SMA 9:5) |
Indirect (SMA 9:6 ja 9:7) |
|
| FI4000410881 | 645,378 | - | 4.61% | - |
| SUBTOTAL A | 645,378 | 4.61 % | ||
Further enquiries
Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com
Lars Lindqvist, CFO, Optomed Plc lars.lindqvist@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology.